{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:23:43Z","timestamp":1790141023488,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T00:00:00Z","timestamp":1463097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijcard.2016.05.009","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T02:51:54Z","timestamp":1463194314000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion"],"prefix":"10.1016","volume":"218","author":[{"given":"Markku S.","family":"Nieminen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cohen-Sol\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"\u00c9des","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Erlikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5790-9707","authenticated-orcid":false,"given":"Vojka","family":"Gorjup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Guarracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Harjola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trygve","family":"Husebye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristjan","family":"Karason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9862-2590","authenticated-orcid":false,"given":"Igor","family":"Katsytadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Kivikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Marenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Masip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Matskeplishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Nessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohdan","family":"Nessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Ntalianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Pichler-Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentti","family":"P\u00f5der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Recio-Mayoral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Rex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rokyta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth H.","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endre","family":"Zima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Pollesello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ijcard.2016.05.009_bb0005","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1161\/CIRCULATIONAHA.105.590091","article-title":"Acute heart failure syndromes: current state and framework for future research","volume":"112","author":"Gheorghiade","year":"2005","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ijcard.2016.05.009_bb0010","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"issue":"20","key":"10.1016\/j.ijcard.2016.05.009_bb0015","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/eurheartj\/ehv051","article-title":"Management of cardiogenic shock","volume":"36","author":"Thiele","year":"2015","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","article-title":"Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan","volume":"159","author":"Papp","year":"2012","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2016.05.009_bb0025","first-page":"227","article-title":"Levosimendan: current data, clinical use and future development","volume":"5","author":"Nieminen","year":"2013","journal-title":"Heart Lung Vessel"},{"key":"10.1016\/j.ijcard.2016.05.009_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2016.02.014","article-title":"Levosimendan meta-analyses: is there a pattern in the effect on mortality?","volume":"209","author":"Pollesello","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"18","key":"10.1016\/j.ijcard.2016.05.009_bb0035","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.ijcard.2016.05.009_bb0040","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0195-668X(03)00438-X","article-title":"Medical Practice Guidelines. Separating science from economics","volume":"24","author":"Priori","year":"2003","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.ijcard.2016.05.009_bb0045","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.05.009_bb0050","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cardfail.2014.07.008","article-title":"Acute heart failure with and without concomitant acute coronary syndromes: patients characteristics, management, and survival","volume":"20","author":"Tarvasm\u00e4ki","year":"2014","journal-title":"J. Card. Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2016.05.009_bb0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchf.2014.10.007","volume":"3","author":"Desta","year":"2015","journal-title":"JACC Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2016.05.009_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.ijcard.2016.05.009_bb0065","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/ejhf.339","article-title":"Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes","volume":"17","author":"De Luca","year":"2015","journal-title":"Eur. J. Heart Fail."},{"issue":"9","key":"10.1016\/j.ijcard.2016.05.009_bb0070","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7326\/0003-4819-149-9-200811040-00005","article-title":"Ten-year trends in the incidence and treatment of cardiogenic shock","volume":"149","author":"Jeger","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.05.009_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2015.10.006","article-title":"Trends in coronary angiography, revascularization, and outcomes of cardiogenic shock complicating non-ST-elevation myocardial infarction","volume":"117","author":"Kolte","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00134-015-4041-5","article-title":"Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance","volume":"42","author":"Mebazaa","year":"2016","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ijcard.2016.05.009_bb0085","series-title":"Acute Heart Failure in the Setting of Acute Coronary Syndromes","first-page":"168","article-title":"Acute Heart Failure","author":"L\u00f3pez-Send\u00f3n","year":"2008"},{"issue":"3\u20135","key":"10.1016\/j.ijcard.2016.05.009_bb0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/15216540152846073","article-title":"Mitochondrial contribution in the progression of cardiac ischemic injury","volume":"52","author":"Di Lisa","year":"2001","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-9149(77)80182-3","article-title":"Correlative classification of clinical and hemodynamic function after acute myocardial infarction","volume":"39","author":"Forrester","year":"1977","journal-title":"Am. J. Cardiol."},{"issue":"24","key":"10.1016\/j.ijcard.2016.05.009_bb0100","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1161\/01.CIR.0000075927.67673.F2","article-title":"Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm","volume":"107","author":"Hochman","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2016.05.009_bb0105","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1152\/japplphysiol.90600.2008","article-title":"Arterial\u2013ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise","volume":"105","author":"Chantler","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"1","key":"10.1016\/j.ijcard.2016.05.009_bb0110","first-page":"2","article-title":"Ventricular\u2013arterial coupling: invasive and non-invasive assessment","volume":"7","author":"Chirinos","year":"2013","journal-title":"Arthritis Res."},{"issue":"19","key":"10.1016\/j.ijcard.2016.05.009_bb0115","first-page":"343","article-title":"Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German\u2013Austria S3 Guideline","volume":"109","author":"Werdan","year":"2012","journal-title":"Dtsch. Arztebl. Int."},{"issue":"3","key":"10.1016\/j.ijcard.2016.05.009_bb0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/HCO.0000000000000057","article-title":"Pharmacologic therapies for acute cardiogenic shock","volume":"29","author":"Nativi-Nicolau","year":"2014","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ijcard.2016.05.009_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009669.pub2","article-title":"Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome","volume":"1","author":"Unverzagt","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/17482941.2011.567284","article-title":"Outcomes of acute heart failure associated with acute coronary syndrome versus other causes","volume":"13","author":"Greenberg","year":"2011","journal-title":"Acute Card. Care"},{"issue":"8","key":"10.1016\/j.ijcard.2016.05.009_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071659","article-title":"The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis","volume":"8","author":"Pirracchio","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00134-010-2073-4","article-title":"Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods","volume":"37","author":"Mebazaa","year":"2011","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ijcard.2016.05.009_bb0145","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijcard.2015.10.240","article-title":"Calcium sensitizers: what have we learned over the last 25years?","volume":"203","author":"Pollesello","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2016.05.009_bb0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00005344-200404000-00011","article-title":"Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart","volume":"43","author":"Kaheinen","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijcard.2016.05.009_bb0155","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0009-9236(97)90139-9","article-title":"Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers","volume":"61","author":"Ukkonen","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ijcard.2016.05.009_bb0160","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1067\/mcp.2000.110972","article-title":"Myocardial efficiency during levosimendan infusion in congestive heart failure","volume":"68","author":"Ukkonen","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ijcard.2016.05.009_bb0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1476-5381.1996.tb15716.x","article-title":"Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs","volume":"119","author":"Pagel","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijcard.2016.05.009_bb0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cardfail.2007.03.005","article-title":"Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation","volume":"13","author":"Zemljic","year":"2007","journal-title":"J. Card. Fail."},{"issue":"10","key":"10.1016\/j.ijcard.2016.05.009_bb0175","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1097\/CCM.0b013e31828e946a","article-title":"Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study","volume":"41","author":"Bragadottir","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ijcard.2016.05.009_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1399-6576.2009.02121.x","article-title":"Dopamine increases renal oxygenation: a clinical study in post-cardiac surgery patients","volume":"54","author":"Redfors","year":"2010","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"6","key":"10.1016\/j.ijcard.2016.05.009_bb0185","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10557-013-6485-6","article-title":"Renal effects of levosimendan: a consensus report","volume":"27","author":"Yilmaz","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"5","key":"10.1016\/j.ijcard.2016.05.009_bb0190","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1152\/japplphysiol.00747.2007","article-title":"ATP-sensitive potassium channels: metabolic sensing and cardioprotection","volume":"103","author":"Zingman","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"1","key":"10.1016\/j.ijcard.2016.05.009_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/bjp.2008.52","article-title":"A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart","volume":"154","author":"du Toit","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00395-009-0064-9","article-title":"Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition","volume":"105","author":"H\u00f6nisch","year":"2010","journal-title":"Basic Res. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2016.05.009_bb0205","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jacc.2004.02.052","article-title":"The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia","volume":"43","author":"Sonntag","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2016.05.009_bb0210","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2015-308137","article-title":"Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion","volume":"102","author":"Tarkia","year":"2016","journal-title":"Heart"},{"issue":"2\u20133","key":"10.1016\/j.ijcard.2016.05.009_bb0215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-2999(01)00997-9","article-title":"Improved survival with simendan after experimental myocardial infarction in rats","volume":"419","author":"Levijoki","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.ijcard.2016.05.009_bb0220","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.bjp.0707157","article-title":"Effects of levosimendan on cardiac remodelling and cardiomyocyte apoptosis in hypertensive Dahl\/Rapp rats","volume":"150","author":"Louhelainen","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"6A","key":"10.1016\/j.ijcard.2016.05.009_bb0225","doi-asserted-by":"crossref","first-page":"26G","DOI":"10.1016\/j.amjcard.2005.07.018","article-title":"Cardioprotection: a new paradigm in the management of acute heart failure syndromes","volume":"96","author":"Maytin","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.05.009_bb0230","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2009.02.058","article-title":"Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure","volume":"53","author":"Cohen-Solal","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2016.05.009_bb0235","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ahj.2004.10.013","article-title":"Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction","volume":"150","author":"De Luca","year":"2005","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0240","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.echo.2005.08.016","article-title":"Effects of levosimendan on left ventricular diastolic function after primary angioplasty for acute anterior myocardial infarction: a Doppler echocardiographic study","volume":"19","author":"De Luca","year":"2006","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"5","key":"10.1016\/j.ijcard.2016.05.009_bb0245","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/eurjhf\/hfs215","article-title":"Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study","volume":"15","author":"Husebye","year":"2013","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0250","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000360933","article-title":"Enhancement of myocardial function and reduction of injury with levosimendan after percutaneous coronary intervention for acute myocardial infarction: a pilot study","volume":"128","author":"Wu","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2016.05.009_bb0255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000357864","article-title":"Efficacy of intravenous levosimendan in patients with heart failure complicated by acute myocardial infarction","volume":"128","author":"Jia","year":"2014","journal-title":"Cardiology"},{"issue":"17","key":"10.1016\/j.ijcard.2016.05.009_bb0260","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0265","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/CCM.0b013e318232962a","article-title":"Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies","volume":"40","author":"Landoni","year":"2012","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00134-014-3604-1","article-title":"Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis","volume":"41","author":"Koster","year":"2015","journal-title":"Intensive Care Med."},{"issue":"8","key":"10.1016\/j.ijcard.2016.05.009_bb0275","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/CCM.0b013e3181809846","article-title":"Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction","volume":"36","author":"Fuhrmann","year":"2008","journal-title":"Crit. Care Med."},{"issue":"7","key":"10.1016\/j.ijcard.2016.05.009_bb0280","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ejheart.2006.01.007","article-title":"Cardiogenic shock after primary percutaneous coronary intervention: effects of levosimendan compared with dobutamine on haemodynamics","volume":"8","author":"Garc\u00eda-Gonz\u00e1les","year":"2006","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0285","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2007.05.018","article-title":"Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty","volume":"128","author":"Dominguez-Rodriguez","year":"2008","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.05.009_bb0290","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijcard.2007.04.143","article-title":"Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty","volume":"127","author":"Samimi-Fard","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.05.009_bb0295","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1097\/01.CCM.0000287524.17358.48","article-title":"Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock","volume":"12","author":"Russ","year":"2007","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.ijcard.2016.05.009_bb0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/17482940701358564","article-title":"Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction","volume":"10","author":"Christoph","year":"2008","journal-title":"Acute Card. Care"},{"key":"10.1016\/j.ijcard.2016.05.009_bb0305","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/VHRM.S8856","article-title":"Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction","volume":"6","author":"Omerovic","year":"2010","journal-title":"Varsc. Health Risk Manag."},{"issue":"6","key":"10.1016\/j.ijcard.2016.05.009_bb0310","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCULATIONAHA.112.111591","article-title":"High levels of circulating epinephrine trigger apical cardiodepression in a \u03b22-adrenergic receptor\/Gi-dependent manner: a new model of Takotsubo cardiomyopathy","volume":"126","author":"Paur","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2016.05.009_bb0315","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1111\/1755-5922.12047","article-title":"Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: a case series","volume":"31","author":"Santoro","year":"2013","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2016.05.009_bb0320","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1097\/CCM.0b013e3181b0314a","article-title":"Right ventricular function in myocardial infarction complicated by cardiogenic shock: improvement with levosimendan","volume":"37","author":"Russ","year":"2009","journal-title":"Crit. Care Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316309111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316309111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T21:27:55Z","timestamp":1536701275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316309111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":64,"alternative-id":["S0167527316309111"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.05.009","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}